OR-AIRSHIP
6.9.2022 15:01:53 CEST | Business Wire | Press release
Airship today published its Mobile App Experience Gap Survey report, which spotlights key internal challenges companies of all sizes face in deploying and improving mobile app experiences for their customers. Findings show that app teams at companies with 1,000 employees or more underperform in optimizing customer experiences across the entire app lifecycle due to internal processes and priorities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220906005387/en/
Despite virtually all marketers and mobile product owners being dependent on developers to improve app user experiences, they view their app enhancement requests happening faster than those implementing them. Nowhere is marketers’ optimism more on display than with enterprise companies, where nearly twice as many marketers as developers say requests were implemented immediately. Developers were twice as likely as marketers to say those requests took a month or multiple months. (Graphic: Business Wire)
Survey results show that mobile app experience (MAX) – as a concept and set of best practices – is still very much a frontier. Many companies struggle to marshal resources and apply agile methods to generate greater value from mobile apps, while others see 3.5X more revenue and 3X greater purchase frequency from customers with the app. The survey identified gaps between technical (developers) and non-technical (marketing) teams with respect to their level of maturity in optimizing mobile app experiences across seven key operational areas:
- App store optimization
- Release cadence
- App onboarding
- Preference centers
- Customer surveys
- Experience optimization
- Team communication
Enterprise companies have the most room for improvement
Developers and marketers in companies with more than 1,000 employees cited the most room for improvement in app store optimization (ASO). A decade of data across organic and paid search in the app stores shows that even the most well-known brand can generate up to 50% of its organic traffic by optimizing for non-branded keywords. Overall, 89% of developers cited “good” or “great” capabilities, either monitoring visibility and conversion rates in the app stores “regularly” or “daily.” Likewise, two-thirds of marketers run ASO experiments monthly, including 27% that do so weekly. However, 20% of developers at enterprise companies admitted they could do better, and 41% of enterprise marketers experiment quarterly or less often — far greater percentages than at smaller companies.
Once an app is downloaded, marketers and mobile product owners are under increasing pressure to make new relationships blossom, especially as paid user acquisition campaigns become less targeted. While most developers say it takes “multiple weeks” to build and deploy a preference center (53%) or a multi-screen feature tutorial or opt-in flow (52%), a third of enterprise developers estimated “a month” or “multiple months” or admitted they don’t have these experiences.
Once mobile app experiences are deployed, there’s a stark gap between app assessment and app improvement. Nearly two-thirds (64%) of respondents assess and adapt multi-screen feature tutorials and opt-in flows at least monthly. However, more than a third of companies only improve these critical onboarding experiences quarterly or less often, jumping to nearly half of enterprise companies. Likewise, almost one-quarter of enterprise marketers and developers were either not sure when they had last updated their app’s preference center or said it had been 1-2 years or longer.
The good news: a decade-plus of apps has improved relationships across diverse teams
For apps to be successful, a customer must find it, download it, value it enough to keep using it, and ultimately self-identify. It takes a village spanning technical and non-technical roles to make that happen. The roles speak different languages, while being dependent on one another to close the gaps between so-so performance and mobile app excellence.
Half of developers (51%) said they work very well with marketing and mobile products owners, with another 37% of developers saying marketers are “decent partners.” Marketers were even more positive about relationships with developers: 62% said they work very well together, and 29% said they are decent partners. Overall, only 12% of developers and 9% of marketers characterized their relationships as “contentious discussions,” though that skewed much higher at the smallest and largest companies. Not a single respondent chose the two most negative characterizations — “difficult” and “uncooperative.”
Marketers’ confidence belies near-total reliance on developers
With nearly three-quarters of marketers and mobile product owners thinking about app enhancements each and every week, and 48 out of 50 relying on developer resources to make improvements happen, it’s a wonder that developers get to focus on job #1 — major new features and QA testing. Twice as many marketers as developers at enterprise and mid-market companies believe their onboarding, adoption, opt-in and data collection enhancement requests are handled “immediately, with the next app update.” In contrast, twice as many developers at enterprise and mid-market companies say these requests take “a month” or “multiple months.”
“Customers today need to be served personally and in their exact moments, which, practically by definition, is happening more in mobile apps than anywhere else,” said Brett Caine, CEO and president, Airship. “The business value of app-centric experiences is self-evident as you see it reinforced every quarter in earnings reports. Yet, despite those game-changing results, many companies struggle to maximize value. App teams and capabilities remain siloed, stuck in a web-era limbo of dependency and promotional approaches that fail to rise to the new customer experience expectation. At Airship, we’re aiming to change all of that with no-code methods that empower the entire team to easily create, automate and adapt native app experiences on the fly in order to capture and sustain more value.”
Download the full Mobile App Experience Gap Survey report.
On September 28 in New York City and October 13 in London, Airship will host “Elevate22: Mastering MAX,” a live, in-person event featuring some of the world’s most valuable brands. Register to hear firsthand how leading brands are creating exponential value for both customers and their businesses.
Methodology
The survey was conducted by Sapio Research among 100 App Developers and 102 App Marketers and Product Owners with active involvement or responsibility for customer-facing mobile apps from companies of over $2 million annual revenue. Respondents were limited to English-speaking countries — U.K., U.S., Australia, Canada, India & Singapore — to ensure questions were clearly understood.
About Airship
No one knows more, does more, or cares more than Airship when it comes to helping brands master mobile app experience (MAX).
From the beginning of apps, Airship powered the first commercial messages and then expanded its data-led approach to all re-engagement channels (mobile wallet, SMS, email), app UX experimentation, no-code native app experience creation and App Store Optimization (ASO). Having powered trillions of mobile app interactions for thousands of global brands, Airship’s technology and deep industry expertise have enabled apps to become the digital center of customer experience, brand loyalty and monetization.
With the Airship App Experience Platform and Gummicube’s ASO technology and expertise, brands now have a complete set of solutions to optimize the entire mobile app customer journey – from the point of discovery to loyalty – driving greater value for everyone involved.
For more information, visit www.airship.com, read our blog or follow us on Twitter, LinkedIn and Facebook.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005387/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
